These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 12091696)

  • 1. Dementing disorders: volumetric measurement of cerebrospinal fluid to distinguish normal from pathologic findings -- feasibility study.
    Thacker NA; Varma AR; Bathgate D; Stivaros S; Snowden JS; Neary D; Jackson A
    Radiology; 2002 Jul; 224(1):278-85. PubMed ID: 12091696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
    Brunnström H; Rawshani N; Zetterberg H; Blennow K; Minthon L; Passant U; Englund E
    Alzheimers Dement; 2010 Mar; 6(2):104-9. PubMed ID: 20298970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
    Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
    Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia.
    Tanna NK; Kohn MI; Horwich DN; Jolles PR; Zimmerman RA; Alves WM; Alavi A
    Radiology; 1991 Jan; 178(1):123-30. PubMed ID: 1984290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease].
    Schonknecht P; Pantel J; Werle E; Hartmann T; Essig M; Baudendistel K; Beyreuther K; Schroder J
    Fortschr Neurol Psychiatr; 2000 Oct; 68(10):439-46. PubMed ID: 11103680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does magnetization transfer ratio (MTR) contribute to the diagnosis and differential diagnosis of the dementias?].
    Hentschel F; Kreis M; Damian M; Krumm B
    Rofo; 2004 Dec; 176(12):1743-9. PubMed ID: 15573284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
    Ernst T; Chang L; Melchor R; Mehringer CM
    Radiology; 1997 Jun; 203(3):829-36. PubMed ID: 9169712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patchy changes in white matter in cranial computerized and magnetic resonance tomography--significance for (differential) diagnosis of dementia of the Alzheimer type and vascular dementia].
    Stoppe G; Staedt J; Bruhn H
    Fortschr Neurol Psychiatr; 1995 Nov; 63(11):425-40. PubMed ID: 8575717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].
    Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K
    Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of the aging brain. Part II. Pathologic conditions.
    Drayer BP
    Radiology; 1988 Mar; 166(3):797-806. PubMed ID: 3277248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the contribution of the importance of neuroimaging for the diagnostics of dementias--comparison to the psychological diagnostics].
    Hentschel F; Kreis M; Damian M; Syren M; Krumm B
    Rofo; 2003 Oct; 175(10):1335-43. PubMed ID: 14556101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of neurodegenerative diseases.
    Mathews VP; Candy EJ; Bryan RN
    Curr Opin Radiol; 1992 Feb; 4(1):89-94. PubMed ID: 1739605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images.
    Kitagaki H; Mori E; Yamaji S; Ishii K; Hirono N; Kobashi S; Hata Y
    Radiology; 1998 Aug; 208(2):431-9. PubMed ID: 9680572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup.
    Wahlund LO; Almkvist O; Blennow K; Engedahl K; Johansson A; Waldemar G; Wolf H
    Top Magn Reson Imaging; 2005 Dec; 16(6):427-37. PubMed ID: 17088692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of dementia and associated risk factors in Japan: The Osaki-Tajiri Project.
    Meguro K; Ishii H; Kasuya M; Akanuma K; Meguro M; Kasai M; Lee E; Hashimoto R; Yamaguchi S; Asada T
    J Neurol Sci; 2007 Sep; 260(1-2):175-82. PubMed ID: 17553526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
    Grossman M; Farmer J; Leight S; Work M; Moore P; Van Deerlin V; Pratico D; Clark CM; Coslett HB; Chatterjee A; Gee J; Trojanowski JQ; Lee VM
    Ann Neurol; 2005 May; 57(5):721-9. PubMed ID: 15852395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration.
    Barnes J; Whitwell JL; Frost C; Josephs KA; Rossor M; Fox NC
    Arch Neurol; 2006 Oct; 63(10):1434-9. PubMed ID: 17030660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated method for identification of patients with Alzheimer's disease based on three-dimensional MR images.
    Arimura H; Yoshiura T; Kumazawa S; Tanaka K; Koga H; Mihara F; Honda H; Sakai S; Toyofuku F; Higashida Y
    Acad Radiol; 2008 Mar; 15(3):274-84. PubMed ID: 18280925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
    Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
    Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.